Chain­Pep­tides Oy

Breaking Antibiotic Resistance in Healthcare

ChainPeptides Oy is an early-stage biotechnology company developing peptide-based antimicrobial solutions for chronic wound care and infection management. The company focuses on a proprietary chain peptide technology platform with broad-spectrum activity against antibiotic-resistant bacteria, aiming to reduce reliance on conventional antibiotics and improve healing outcomes.

A key innovation under development is a smart antimicrobial plaster that integrates chain peptides into advanced wound dressings, with the long-term vision of combining antimicrobial peptides with biosensing and monitoring capabilities. ChainPeptides collaborates closely with academic and clinical partners to translate cutting-edge science into practical healthcare products for unmet medical needs.

ChainPeptides Oy is developing a proprietary antimicrobial peptide technology platform designed to combat antibiotic-resistant infections. The company’s chain peptides are engineered for stability and broad-spectrum antimicrobial activity and are intended for use in medical devices and advanced wound-care products.

The main product under development is a smart antimicrobial plaster for diabetic foot ulcers, with real time detection of infection and integrating chain peptides into next-generation wound dressings with the long-term vision of combining antimicrobial protection with sensing and monitoring capabilities.

• Biopharma
• Chronic disease management
• Health tech
• Life Sciences, including food safety and control
• Med tech
• Preventive care